Sony Innovation Fund by Innovation Growth Ventures is a venture capital fund established in 2019 by Sony Corporation, Daiwa Capital Holdings Co., Ltd. and external limited partners.
Portfolio
3
companies
Divido
Divido provides a white-label platform for retail finance and point of sale payments.
Huma Therapeutics
Huma Therapeutics builds digital health platforms for care and research.
Token
Open banking payments platform facilitating account to account transactions.
Gen Tsuchikawa
Chief Investment Manager for Sony Innovation Fund and CEO and Chief Investment Officer for Innovation Growth Ventures
The funding round was led by HSBC and ING to fuel international growth.
"The retail finance market is in a period of exponential growth, expected to hit $2.5 trillion next year. This provides banks with the opportunity to increase lending revenue, diversify their portfolio and neutralise the threat from new entrants."
The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.
"This is a pivotal moment in Huma’s development. We have exceptional partners and strategic investors who will support us in our mission to help people worldwide live longer and fuller lives. We’re already demonstrating how ‘hospital at home’ can transform healthcare, and how decentralized clinical trials can advance research in ways that weren’t imaginable even one year ago. Now we want to accelerate the pace of change and continue to innovate for better care and research worldwide."
The funding round was led by SBI Investment alongside Sony Innovation Fund by IGV and existing backers.
"The market’s appetite for open payments accelerated dramatically last year as more merchants and payment providers have tuned into the cost and efficiency gains that they offer,"
